170 related articles for article (PubMed ID: 4690469)
21. Bioavailability of digoxin: what the clinician needs to know.
Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
Conn Med; 1974 May; 38(5):230-2. PubMed ID: 4831099
[No Abstract] [Full Text] [Related]
22. The general problem of drug bioavailability and its assessment in man.
Smith RN
Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
[No Abstract] [Full Text] [Related]
23. Bioavailability of peroral dosage forms.
Ritschel WA
Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
[No Abstract] [Full Text] [Related]
24. Some factors affecting bioavailability of drug products.
Lach JL
J Iowa Med Soc; 1972 Aug; 62(8):441-2 passim. PubMed ID: 5044776
[No Abstract] [Full Text] [Related]
25. Proceedings: Bioavailability and therapeutic efficacy.
Withey RJ
Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
[No Abstract] [Full Text] [Related]
26. Statistical problems in interpreting comparative bioavailability trials.
Westlake WJ
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
[TBL] [Abstract][Full Text] [Related]
27. Transfer functions obtained by the rule of corresponding fractional areas.
Dost FH; von Hattingberg HM
Eur J Clin Pharmacol; 1971 Sep; 3(4):252-4. PubMed ID: 5151310
[No Abstract] [Full Text] [Related]
28. Biopharmaceutics and applied pharmacy.
Krówczyński L
Pharmazie; 1971 Nov; 26(11):659. PubMed ID: 5154316
[No Abstract] [Full Text] [Related]
29. Drug doses for children. A rational approach to an old problem.
Habersang R; Kauffman RE
J Kans Med Soc; 1974 Mar; 75(3):98-103. PubMed ID: 4593019
[No Abstract] [Full Text] [Related]
30. Absorption of digoxin from different oral preparations in normal subjects during steady state.
Huffman DH; Manion CV; Azarnoff DL
Clin Pharmacol Ther; 1974 Aug; 16(2):310-7. PubMed ID: 4850376
[No Abstract] [Full Text] [Related]
31. The formulation of aspirin.
Martin BK
Adv Pharm Sci; 1971; 3():107-71. PubMed ID: 4947388
[No Abstract] [Full Text] [Related]
32. The basis for selection of the dosage form and source of a drug.
Levy G; Barr WH
Ration Drug Ther; 1972 Jan; 6(1):1-7. PubMed ID: 5084612
[No Abstract] [Full Text] [Related]
33. [Bioavailability and biopharmaceutics].
Colombo BM; Colombo MM; De Fusco R
Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
[No Abstract] [Full Text] [Related]
34. The use of physical and animal models to assess bioavailability.
Barr WH
Pharmacology; 1972; 8(1):55-101. PubMed ID: 4630161
[No Abstract] [Full Text] [Related]
35. Drug bioavailability studies.
Wagner JG
Hosp Pract; 1977 Jan; 12(1):119-27. PubMed ID: 838484
[TBL] [Abstract][Full Text] [Related]
36. Bioavailability, clinical effectiveness, and the public interest.
Levy G
Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
[No Abstract] [Full Text] [Related]
37. [Biopharmacy and pharmacokinetics].
Janků I
Pharmazie; 1971 Nov; 26(11):660. PubMed ID: 5154317
[No Abstract] [Full Text] [Related]
38. Proceedings: Influence of formulation on absorption and clinical effect of digoxin.
Shaw TR; Howard MR; Hamer J
Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478
[No Abstract] [Full Text] [Related]
39. Kinetics of drug absorption.
Kitler ME; Lamy PP
Pharm Acta Helv; 1971 Apr; 46(4):193-209. PubMed ID: 5575009
[No Abstract] [Full Text] [Related]
40. Aspects of pharmacokinetics and biopharmaceutics in relation to drug activity.
Wagner JG
Am J Pharm Sci Support Public Health; 1969; 141(1):5-20. PubMed ID: 5776857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
